Skip to main content
. 2013 Apr 1;3(2):e25102. doi: 10.4161/biom.25102

Table 4. Design matrix evaluation for response surface quadratic model of PEGylated nanoparticles bearing temozolomide.

Table 4A
Degrees of freedom for evaluation
Model
14
Residuals
67
Lack of Fit
66
Pure Error
1
Corr Total 81
Table 4B
Term Standard error** VIF Ri-squared Power at 5% α level for effect of
0.5 Std. Dev. 1 Std. Dev. 2 Std. Dev.
A
0.136083
1
0
44.10%
95.20%
99.90%
B
0.136083
1
0
44.10%
95.20%
99.90%
C
0.136083
1
0
44.10%
95.20%
99.90%
D
0.136083
1
0
44.10%
95.20%
99.90%
AB
0.166667
1
0
31.50%
84.10%
99.90%
AC
0.166667
1
0
31.50%
84.10%
99.90%
AD
0.166667
1
0
31.50%
84.10%
99.90%
BC
0.166667
1
0
31.50%
84.10%
99.90%
BD
0.166667
1
0
31.50%
84.10%
99.90%
CD
0.166667
1
0
31.50%
84.10%
99.90%
A^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
B^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
C^2
0.233069
1.001626
0.0016234
56.10%
98.80%
99.90%
D^2 0.233069 1.001626 0.0016234 56.10% 98.80% 99.90%